semaglutide compound going away Now that shortages of and tirzepatide are resolved, you may wonder if compounded GLP-1s are away. Here's why they haven't disappeared entirely. 🔗 Check GoodRx for savings at the link Semaglutide for weight loss |

Converting non-food ingredients into GLP-1 companion ingredients Nagase Viita transforms cosmetic ingredients into food ingredients for GLP-1 Japanese company Nagase Viita Co., Ltd

The chance to work on such high-impact initiatives has been a key part of the opportunities Ive had at Lilly, where real advances in therapy are within reach

What is the CAGR of this market

These include: Increased appetite and food cravings , which may work against Wegovy's appetite-suppressing effects Insulin resistance and elevated blood glucose levels , potentially leading to steroid-induced diabetes Fluid retention and weight gain , particularly in the face, neck, and trunk (cushingoid features) Redistribution of body fat to central areas Muscle wasting , which can reduce metabolic rate Patients taking both medications may experience reduced weight loss efficacy compared to those taking Wegovy alone, though the appetite-suppressing effects of Wegovy may help mitigate steroid-induced hunger

What stands out is how rapidly innovation is translating into real-world impact and how this will reshape treatment pathways, commercial strategies, and capability needs across pharma